Neurourol Urodyn. 2020 Jan;39(1):45-57. doi: 10.1002/nau.24211. Epub 2019 Nov 13.
PMID:31724222
Molecular Mechanism Operating in Animal Models of Neurogenic Detrusor Overactivity: A Systematic Review Focusing on Bladder Dysfunction of Neurogenic Origin.
Ferreira A, Nascimento D, Cruz CD.
Int J Mol Sci. 2023 Feb 7;24(4):3273. doi: 10.3390/ijms24043273.
PMID:36834694
Adverse Effects of Intravesical OnabotulinumtoxinA Injection in Patients with Idiopathic Overactive Bladder or Neurogenic Detrusor Overactivity: A Systematic Review and Meta-Analysis of Randomized Controlled Studies.
Yu PH, Wang CC.
Toxins (Basel). 2024 Aug 5;16(8):343. doi: 10.3390/toxins16080343.
PMID:39195753
Treatment of neurogenic detrusor overactivity and overactive bladder with Botox (onabotulinumtoxinA): Development, insights, and impact.
Nitti V, Haag-Molkenteller C, Kennelly M, Chancellor M, Jenkins B, Schurch B.
Medicine (Baltimore). 2023 Jul 1;102(S1):e32377. doi: 10.1097/MD.0000000000032377.
PMID:37499088
Chapter 5: Clinical data in neurogenic detrusor overactivity (NDO) and overactive bladder (OAB).